Skip to main content
Erschienen in:

23.09.2020 | Original Article

Patient reported experiences following laparoscopic prophylactic bilateral salpingo-oophorectomy or salpingectomy in an ambulatory care hospital

verfasst von: Rachel Trister, Michelle Jacobson, Patricia Nguyen, Mara Sobel, Lisa Allen, Steven A. Narod, Joanne Kotsopoulos

Erschienen in: Familial Cancer | Ausgabe 2/2021

Einloggen, um Zugang zu erhalten

Abstract

Women at risk of developing ovarian cancer because of a BRCA1 or BRCA2 pathogenic variant are candidates for prophylactic bilateral salpingo-oophorectomy (BSO). While BSO surgeries are routinely performed, to our knowledge there are no studies that have examined patient-reported experiences following laparoscopic BSO performed in an ambulatory care setting. The objective of this study was to examine whether women undergoing prophylactic laparoscopic BSO felt they were adequately informed about post-operative outcomes. A telephone interview was conducted among 46 women undergoing laparoscopic BSO to collect detailed information regarding surgical outcomes, complications, symptoms, and time to return to daily activities. The average age at surgery was 45.0 years (range 34–66) and 67% of women underwent BSO prior to age 50. The mean reported hospital stay was 7.2 h (range 4–12 h) and at time of discharge, 78% of the women felt well enough to go home. None of the women required a readmission to hospital. Forty-three percent (n = 20) of the women did not feel well informed about what to expect post-operatively. Most of the patient-reported outcomes (including pain, vaginal bleeding, and nausea/vomiting) were expected and patient-reported menopausal symptoms were more common among women who were premenopausal at surgery. In terms of returning to regular activities, premenopausal women (n = 36) resumed sexual activity on average at 43 days (range 2–365), which is later than postmenopausal women (n = 15) at 19 days (range 7–30). On average, women returned to full-time work in 16 days (range 1–56 days). Despite patients receiving pre-surgery counselling, our findings suggest that there is a need to provide supplemental, reinforcing patient materials in preparing patients for what to expect after surgery.
Literatur
1.
Zurück zum Zitat Xie L, Semenciw R, Mery L (2015) Cancer incidence in Canada: trends and projections (1983–2032). Health Promot Chronic Dis Prev Can 35(Suppl 1):2–186CrossRef Xie L, Semenciw R, Mery L (2015) Cancer incidence in Canada: trends and projections (1983–2032). Health Promot Chronic Dis Prev Can 35(Suppl 1):2–186CrossRef
2.
Zurück zum Zitat Kotsopoulos J, Gronwald J, Karlan B et al (2018) Age-specific ovarian cancer risks among women with a BRCA1 or BRCA2 mutation. Gynecol Oncol 150:85–91CrossRef Kotsopoulos J, Gronwald J, Karlan B et al (2018) Age-specific ovarian cancer risks among women with a BRCA1 or BRCA2 mutation. Gynecol Oncol 150:85–91CrossRef
3.
Zurück zum Zitat Armstrong K, Sanford Schwartz J, Randall T, Rubin SC, Weber B (2004) Hormone replacement therapy and life expectancy after prophylactic oophorectomy in women with BRCA1/2 mutations: a decision analysis. J Clin Oncol 22:1045–1054CrossRef Armstrong K, Sanford Schwartz J, Randall T, Rubin SC, Weber B (2004) Hormone replacement therapy and life expectancy after prophylactic oophorectomy in women with BRCA1/2 mutations: a decision analysis. J Clin Oncol 22:1045–1054CrossRef
4.
Zurück zum Zitat National Comprehensive Cancer Network. Genetic/familial high-risk assessment: breast and ovarian. NCCN Guidelines version 3.2019. Accessed 21 May 2019. National Comprehensive Cancer Network. Genetic/familial high-risk assessment: breast and ovarian. NCCN Guidelines version 3.2019. Accessed 21 May 2019.
5.
Zurück zum Zitat Gien LT, Kupets R, Covens A (2011) Feasibility of same-day discharge after laparoscopic surgery in gynecologic oncology. Gynecol Oncol 121:339–343CrossRef Gien LT, Kupets R, Covens A (2011) Feasibility of same-day discharge after laparoscopic surgery in gynecologic oncology. Gynecol Oncol 121:339–343CrossRef
6.
Zurück zum Zitat Dedden SJ, Geomini PMAJ, Huirne JAF, Bongers MY (2017) Vaginal and laparoscopic hysterectomy as an outpatient procedure: a systematic review. Eur J Obstet Gynecol Reprod Biol 216:212–223CrossRef Dedden SJ, Geomini PMAJ, Huirne JAF, Bongers MY (2017) Vaginal and laparoscopic hysterectomy as an outpatient procedure: a systematic review. Eur J Obstet Gynecol Reprod Biol 216:212–223CrossRef
8.
Zurück zum Zitat Lozada Y, Bhagavath B (2017) A Review of laparoscopic salpingo-oophorectomy: technique and perioperative considerations. J Minim Invasive Gynecol 24:364–370CrossRef Lozada Y, Bhagavath B (2017) A Review of laparoscopic salpingo-oophorectomy: technique and perioperative considerations. J Minim Invasive Gynecol 24:364–370CrossRef
9.
Zurück zum Zitat Gendy R, Walsh CA, Walsh SR, Karantanis E (2011) Vaginal hysterectomy versus total laparoscopic hysterectomy for benign disease: a metaanalysis of randomized controlled trials. Am J Obstet Gynecol 204:388.e1-8CrossRef Gendy R, Walsh CA, Walsh SR, Karantanis E (2011) Vaginal hysterectomy versus total laparoscopic hysterectomy for benign disease: a metaanalysis of randomized controlled trials. Am J Obstet Gynecol 204:388.e1-8CrossRef
10.
Zurück zum Zitat Yi YX, Zhang W, Zhou Q, Guo WR, Su Y (2011) Laparoscopic-assisted vaginal hysterectomy vs abdominal hysterectomy for benign disease: a meta-analysis of randomized controlled trials. Eur J Obstet Gynecol Reprod Biol 159:1–18CrossRef Yi YX, Zhang W, Zhou Q, Guo WR, Su Y (2011) Laparoscopic-assisted vaginal hysterectomy vs abdominal hysterectomy for benign disease: a meta-analysis of randomized controlled trials. Eur J Obstet Gynecol Reprod Biol 159:1–18CrossRef
11.
Zurück zum Zitat Zhang Z, Zhuang Y, Ouyang F, Zhang A, Zeng B, Gu M (2012) Penehyclidine enhances the efficacy of tropisetron in prevention of PONV following gynecological laparoscopic surgery. J Anesth 26:864–869CrossRef Zhang Z, Zhuang Y, Ouyang F, Zhang A, Zeng B, Gu M (2012) Penehyclidine enhances the efficacy of tropisetron in prevention of PONV following gynecological laparoscopic surgery. J Anesth 26:864–869CrossRef
12.
Zurück zum Zitat Acalovschi I (2002) Postoperative nausea and vomiting. Curr Anaesth Crit Care 13:37–43CrossRef Acalovschi I (2002) Postoperative nausea and vomiting. Curr Anaesth Crit Care 13:37–43CrossRef
13.
Zurück zum Zitat Tas B, Donatsky AM, Gogenur I (2013) Techniques to reduce shoulder pain after laparoscopic surgery for benign gynaecological disease: a systematic review. Gynecol Surg 10:169–175CrossRef Tas B, Donatsky AM, Gogenur I (2013) Techniques to reduce shoulder pain after laparoscopic surgery for benign gynaecological disease: a systematic review. Gynecol Surg 10:169–175CrossRef
14.
Zurück zum Zitat Hohlrieder M, Brimacombe J, Eschertzhuber S, Ulmer H, Keller C (2007) A study of airway management using the ProSeal LMA compared with the tracheal tube on postoperative analgesia requirements following gynecological laparoscopic surgery. Anaesthesia 62:913–918CrossRef Hohlrieder M, Brimacombe J, Eschertzhuber S, Ulmer H, Keller C (2007) A study of airway management using the ProSeal LMA compared with the tracheal tube on postoperative analgesia requirements following gynecological laparoscopic surgery. Anaesthesia 62:913–918CrossRef
15.
Zurück zum Zitat Kaloo P, Armstrong S, Kaloo C, Jordan V (2019) Interventions to reduce shoulder pain following gynaecological laparoscopic procedures. Cochrane Database Syst Rev 1:CD011101PubMed Kaloo P, Armstrong S, Kaloo C, Jordan V (2019) Interventions to reduce shoulder pain following gynaecological laparoscopic procedures. Cochrane Database Syst Rev 1:CD011101PubMed
16.
Zurück zum Zitat Hayden P, Cowman S (2011) Anaesthesia for laparoscopic surgery. Contin Educ Anaesth Crit Care Pain 11:177–180CrossRef Hayden P, Cowman S (2011) Anaesthesia for laparoscopic surgery. Contin Educ Anaesth Crit Care Pain 11:177–180CrossRef
17.
Zurück zum Zitat Dixon JB, Reuben Y, Halket C, O’Brien PE (2005) Shoulder pain is a common problem following laparoscopic adjustable gastric band surgery. Obes Surg 15:1111–1117CrossRef Dixon JB, Reuben Y, Halket C, O’Brien PE (2005) Shoulder pain is a common problem following laparoscopic adjustable gastric band surgery. Obes Surg 15:1111–1117CrossRef
18.
Zurück zum Zitat Wang JJ, Ho ST, Liu HS, Ho CM (2000) Prophylactic antiemetic effect of dexamethasone in women undergoing ambulatory laparoscopic surgery. Br J Anaesth 84:459–462CrossRef Wang JJ, Ho ST, Liu HS, Ho CM (2000) Prophylactic antiemetic effect of dexamethasone in women undergoing ambulatory laparoscopic surgery. Br J Anaesth 84:459–462CrossRef
19.
Zurück zum Zitat Michelsen TM, Dorum A, Trope CG, Fossa SD, Dahl AA (2009) Fatigue and quality of life after risk-reducing salpingo-oophorectomy in women at increased risk for hereditary breast-ovarian cancer. Int J Gynecol Cancer 19:1029–1036CrossRef Michelsen TM, Dorum A, Trope CG, Fossa SD, Dahl AA (2009) Fatigue and quality of life after risk-reducing salpingo-oophorectomy in women at increased risk for hereditary breast-ovarian cancer. Int J Gynecol Cancer 19:1029–1036CrossRef
20.
Zurück zum Zitat Corney RH, Crowther ME, Everett H, Howells A, Shepherd JH (1993) Psychosexual dysfunction in women with gynaecological cancer following radical pelvic surgery. Br J Obstet Gynaecol 100:73–78CrossRef Corney RH, Crowther ME, Everett H, Howells A, Shepherd JH (1993) Psychosexual dysfunction in women with gynaecological cancer following radical pelvic surgery. Br J Obstet Gynaecol 100:73–78CrossRef
21.
Zurück zum Zitat Fang CY, Cherry C, Devarajan K, Li T, Malick J, Daly MB (2009) A prospective study of quality of life among women undergoing risk-reducing salpingo-oophorectomy versus gynecologic screening for ovarian cancer. Gynecol Oncol 112:594–600CrossRef Fang CY, Cherry C, Devarajan K, Li T, Malick J, Daly MB (2009) A prospective study of quality of life among women undergoing risk-reducing salpingo-oophorectomy versus gynecologic screening for ovarian cancer. Gynecol Oncol 112:594–600CrossRef
22.
Zurück zum Zitat Hall E, Finch A, Jacobson M et al (2019) Effects of bilateral salpingo-oophorectomy on menopausal symptoms and sexual functioning among women with a BRCA1 or BRCA2 mutation. Gynecol Oncol 152:145–150CrossRef Hall E, Finch A, Jacobson M et al (2019) Effects of bilateral salpingo-oophorectomy on menopausal symptoms and sexual functioning among women with a BRCA1 or BRCA2 mutation. Gynecol Oncol 152:145–150CrossRef
23.
Zurück zum Zitat Tucker PE, Bulsara MK, Salfinger SG, Jit-Sun Tan J, Green H, Cohen PA (2016) The effects of pre-operative menopausal status and hormone replacement therapy (HRT) on sexuality and quality of life after risk-reducing salpingo-oophorectomy. Maturitas 85:42–48CrossRef Tucker PE, Bulsara MK, Salfinger SG, Jit-Sun Tan J, Green H, Cohen PA (2016) The effects of pre-operative menopausal status and hormone replacement therapy (HRT) on sexuality and quality of life after risk-reducing salpingo-oophorectomy. Maturitas 85:42–48CrossRef
24.
Zurück zum Zitat Sanders AP, Amir H, Fong CJ, Murji A, Solnik MJ (2020) Returning to work following minimally invasive hysterectomy. J Obstet Gynaecol Can 42:80–83CrossRef Sanders AP, Amir H, Fong CJ, Murji A, Solnik MJ (2020) Returning to work following minimally invasive hysterectomy. J Obstet Gynaecol Can 42:80–83CrossRef
25.
Zurück zum Zitat Bouwsma EVA, Anema JR, Vonk Noordegraaf A, de Vet HCW, Huirne JAF (2017) Using patient data to optimize an expert-based guideline on convalescence recommendations after gynecological surgery: a prospective cohort study. BMC Surg 17:129CrossRef Bouwsma EVA, Anema JR, Vonk Noordegraaf A, de Vet HCW, Huirne JAF (2017) Using patient data to optimize an expert-based guideline on convalescence recommendations after gynecological surgery: a prospective cohort study. BMC Surg 17:129CrossRef
26.
Zurück zum Zitat Horvath KJ (2003) Postoperative recovery at home after ambulatory gynecologic laparoscopic surgery. J Perianesth Nurs 18:324–334CrossRef Horvath KJ (2003) Postoperative recovery at home after ambulatory gynecologic laparoscopic surgery. J Perianesth Nurs 18:324–334CrossRef
27.
Zurück zum Zitat Kleinbeck SVM, Eells KR (1997) Monitoring postdischarge ambulatory surgical recovery costs and outcomes. Surg Serv Manag 3:33–35 Kleinbeck SVM, Eells KR (1997) Monitoring postdischarge ambulatory surgical recovery costs and outcomes. Surg Serv Manag 3:33–35
28.
Zurück zum Zitat Oberle K, Allen M, Lynkowski P (1994) Follow-up of same day surgery patients: a study of patient concerns. AORN J 59:1016–1025CrossRef Oberle K, Allen M, Lynkowski P (1994) Follow-up of same day surgery patients: a study of patient concerns. AORN J 59:1016–1025CrossRef
29.
Zurück zum Zitat Alshenqeeti H (2014) Interviewing as a data collection method: a critical review. Engl Linguist Res 3:39–45 Alshenqeeti H (2014) Interviewing as a data collection method: a critical review. Engl Linguist Res 3:39–45
Metadaten
Titel
Patient reported experiences following laparoscopic prophylactic bilateral salpingo-oophorectomy or salpingectomy in an ambulatory care hospital
verfasst von
Rachel Trister
Michelle Jacobson
Patricia Nguyen
Mara Sobel
Lisa Allen
Steven A. Narod
Joanne Kotsopoulos
Publikationsdatum
23.09.2020
Verlag
Springer Netherlands
Erschienen in
Familial Cancer / Ausgabe 2/2021
Print ISSN: 1389-9600
Elektronische ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-020-00208-y

Neu im Fachgebiet Onkologie

Weniger PSA-Screening, mehr fortgeschrittene Tumoren

Eine Empfehlung gegen das Prostatakrebs-Screening, die mehrere Jahre in den Leitlinien des Royal Australasian College of General Practitioners gegeben wurde, hat sich nicht nur auf die Rate von PSA-Tests negativ ausgewirkt.

Schützt kutane Autoimmunität vor Hauttumoren?

Schwedische Registerdaten deuten auf ein geringeres Risiko für bestimmte Hauttumoren bei Personen mit Vitiligo oder autoimmuner Alopezie. Wie es dazu kommt, ist dagegen unklar.

Muss man wirklich auch die letzte Krebszelle eliminieren?

Genauere Prognoseabschätzung, bessere Therapiesteuerung und eine schnellere Entwicklung innovativer Behandlungsansätze – der Messung der minimalen Resterkrankung (MRD) wird ein enormes Potenzial attestiert. Eine Übersichtsarbeit unterstreicht jetzt aber: Es gibt noch blinde Flecken.

Zufällig entdeckter Barrett-Ösophagus nicht weniger risikobehaftet

Fälle von Barrett-Ösophagus, die bei einer ÖGD als Zufallsbefund zutage treten, sind keine Seltenheit und auch keineswegs harmloser als Barrett-Metaplasien, die bei gezieltem Screening oder Surveillance-Untersuchungen entdeckt werden. 

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.